PP_1170x120_10-25-21

Fresenius Medical Care North America (FMCNA)

Aetna and FMCNA announce agreement for end-stage renal disease

Aetna and FMCNA announce agreement for end-stage renal disease

HARTFORD — Aetna, a CVS Health company, and Fresenius Medical Care North America (FMCNA) today announced they have enhanced their value-based care agreement to support the health care needs of Aetna Medicare Advantage members with end-stage renal disease (ESRD). FMCNA provides support services that focus on the full continuum of care for approximately 4,500 Aetna